These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2910362

  • 1. In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia.
    Karp JE, Donehower RC, Enterline JP, Dole GB, Fox MG, Burke PJ.
    Blood; 1989 Jan; 73(1):24-30. PubMed ID: 2910362
    [Abstract] [Full Text] [Related]

  • 2. Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Blood; 1987 Apr; 69(4):1134-40. PubMed ID: 3470054
    [Abstract] [Full Text] [Related]

  • 3. An in vitro model to predict clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Burke PJ.
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):172-81. PubMed ID: 3473676
    [Abstract] [Full Text] [Related]

  • 4. Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.
    Karp JE, Burke PJ, Donehower RC.
    Leukemia; 1990 Aug; 4(8):553-6. PubMed ID: 2201833
    [Abstract] [Full Text] [Related]

  • 5. Correlation of the proliferative index of residual leukemia with outcome in patients treated with sequential high dose ara-C and asparaginase.
    Powell BL, Kute TE, Craig JB, Lyerly ES, Gregory BW, Do KA, Contento MM, Capizzi RL.
    Leukemia; 1990 May; 4(5):316-20. PubMed ID: 2388477
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.
    Crews KR, Gandhi V, Srivastava DK, Razzouk BI, Tong X, Behm FG, Plunkett W, Raimondi SC, Pui CH, Rubnitz JE, Stewart CF, Ribeiro RC.
    J Clin Oncol; 2002 Oct 15; 20(20):4217-24. PubMed ID: 12377965
    [Abstract] [Full Text] [Related]

  • 10. Differential effect of GM-CSF pretreatment on intracellular Ara-C metabolism in normal bone marrow mononuclear cells vs acute myeloid leukemia (AML) blasts.
    Reuter C, Schleyer E, Rolf C, Wörmann B, Büchner T, Hiddemann W.
    Leukemia; 1997 Apr 15; 11(4):561-71. PubMed ID: 9096697
    [Abstract] [Full Text] [Related]

  • 11. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
    Karp JE, Passaniti A, Gojo I, Kaufmann S, Bible K, Garimella TS, Greer J, Briel J, Smith BD, Gore SD, Tidwell ML, Ross DD, Wright JJ, Colevas AD, Bauer KS.
    Clin Cancer Res; 2005 Dec 01; 11(23):8403-12. PubMed ID: 16322302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
    Schiller M, Hohenlöchter B, Schulze-Westhoff P, Zimmermann M, Ritter J, Jürgens H, Boos J.
    Klin Padiatr; 1996 Dec 01; 208(4):151-9. PubMed ID: 8926681
    [Abstract] [Full Text] [Related]

  • 16. Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia.
    Karp JE, Smith BD, Levis MJ, Gore SD, Greer J, Hattenburg C, Briel J, Jones RJ, Wright JJ, Colevas AD.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4467-73. PubMed ID: 17671131
    [Abstract] [Full Text] [Related]

  • 17. Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia.
    Gandhi V, Estey E, Du M, Nowak B, Keating MJ, Plunkett W.
    Clin Cancer Res; 1995 Feb 01; 1(2):169-78. PubMed ID: 9815970
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.